Novartis trademark-sale ruling clarifies boundaries of Indian IP transfers
Novartis’s sale of Indian pharmaceutical trademarks was an outright transfer despite territorial and contractual restrictions, a Mumbai tax tribunal ruled. The Income Tax Appellate Tribunal rejected the royalty treatment of the 4.33...To view the full article, register now.
Already a subscriber? Click here to view full article